MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on November 24, 2004; DOI: 10.1124/mol.104.002097


0026-895X/05/6703-648-654$20.00
Mol Pharmacol 67:648-654, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.002097v1
67/3/648    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robay, A.
Right arrow Articles by Gauthier, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robay, A.
Right arrow Articles by Gauthier, C.
ORIGINAL ARTICLE

Transfected {beta}3- but Not {beta}2-Adrenergic Receptors Regulate Cystic Fibrosis Transmembrane Conductance Regulator Activity via a New Pathway Involving the Mitogen-Activated Protein Kinases Extracellular Signal-Regulated Kinases

Amal Robay, Gilles Toumaniantz, Véronique Leblais, and Chantal Gauthier

Institut du Thorax, Institut National de la Sante et de la Recherche Medicale U533, Faculté de Médecine, Nantes, France (A.R., G.T., C.G.); Laboratoire de Pharmacologie de la Faculté de Pharmacie, Institut National de la Sante et de la Recherche Medicale EMI-0356, Université Victor Segalen Bordeaux 2, Bordeaux, France (V.L.); and Faculté des Sciences et Techniques, Nantes, France (C.G.)

Abstract

We have shown previously that in a heterologous mammalian expression system A549 cells, {beta}3-adrenoceptor ({beta}3-AR) stimulation regulates the activity of cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. The present investigation was carried out to determine the signaling pathway involved in this regulation. A549 cells were intranuclearly injected with plasmids encoding human CFTR and {beta}3-AR. CFTR activity was functionally assessed by microcytofluorimetry. The application of 1 µM 4-[3-t-butylamino-2-hydroxypropoxy]benzimidazol-2-1 hydrochloride (CGP-12177), a {beta}3-AR agonist, produced a CFTR activation that was not abolished by protein kinase A inhibitors. In pertussis toxin-pretreated cells, the CFTR activation induced by CGP-12177 was abolished. The overexpression of {beta}-adrenoceptor receptor kinase, an inhibitor of {beta}{gamma} subunits, abolished the CGP-12177–induced CFTR activation, suggesting the involvement of {beta}{gamma} subunits of Gi/o proteins. The pretreatment of A549 cells with selective inhibitors of either phosphoinositide 3-kinase (PI3K), wortmannin, and 2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride (LY294002), or extracellular signal-regulated kinases 1 and 2 (ERK1/2) mitogen-activated protein kinase (MAPK), 2'-amino-3'-methoxyflavone (PD98059), and 1,4-diamino-2,3-dicyano-1,4-bis(2-aminophynyltio)butadiene (U0126), abolished the effects of CGP-12177 on the CFTR activity. Immunohistochemical assays showed that only the cells expressing {beta}3-AR exhibited MAPK activation in response to CGP-12177. Furthermore, CFTR activity increased in cells pretreated with 10% fetal bovine serum both in A549 cells injected only with CFTR and in T84 cells, which endogenously express CFTR, indicating that CFTR activity can be regulated by the MAPK independently of the {beta}3-AR stimulation. In conclusion, we have demonstrated that CFTR is regulated through a Gi/o/PI3K/ERK1/2 MAPK signaling cascade dependently or not on an activation of {beta}3-ARs. This pathway represents a new regulation for CFTR.


Received May 25, 2004; accepted November 23, 2004

Address correspondence to: Dr. Chantal Gauthier, Institut du Thorax, Inserm U533, Faculté de Médecine, 1 rue Gaston Veil, BP 53508, F-44035 Nantes, France. E-mail: chantal.gauthier{at}nantes.inserm.fr




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
A. P. Joy and E. A. Cowley
8-iso-PGE2 Stimulates Anion Efflux from Airway Epithelial Cells via the EP4 Prostanoid Receptor
Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 143 - 152.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
F. Bossard, A. Robay, G. Toumaniantz, S. Dahimene, F. Becq, J. Merot, and C. Gauthier
NHE-RF1 protein rescues {Delta}F508-CFTR function
Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1085 - L1094.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics